Argininosuccinate synthetase (AS) is the rate-limiting enzyme of both the urea and arginine-citrulline cycles. In mammals, deficiency of AS leads to citrullinemia, a debilitating and often fatal autosomal recessive urea cycle disorder, whereas its overexpression for sustained nitric oxide production via the arginine-citrulline cycle leads to the potentially fatal hypotension associated with septic and cytokine-induced circulatory shock. The crystal structures of Escherichia coli argininosuccinate synthetase (EAS) in complex with ATP and with ATP and citrulline have been determined at 2.0-Å resolution. These are the first EAS structures to be solved in the presence of a nucleotide substrate and clearly identify the residues that interact with both ATP and citrulline. Two distinct conformations are revealed for ATP, both of which are believed to be catalytically relevant. In addition, comparisons of these EAS structures with those of the apoenzyme and EAS complexed with aspartate and citrulline (Lemke, C. T., and Howell, P. L. (2001) Structure (Lond.) 9, 1153-1164) provide structural evidence of ATP-induced conformational changes in the nucleotide binding domain. Combined, these structures also provide structural explanations of some of the observed kinetic properties of the enzyme and have enabled a detailed enzymatic mechanism of AS catalysis to be proposed.Argininosuccinate synthetase (AS 1 ; EC 6.3.4.5) catalyzes the reversible conversion of citrulline, aspartate, and ATP to argininosuccinate, AMP, and inorganic pyrophosphate (Fig. 1). There are three important metabolic processes that require this catalysis. First, in all organisms AS catalyzes the penultimate step in the biosynthesis of arginine, one of the 20 amino acid building blocks of life, and a precursor for the synthesis of several other biomolecules. Second, AS participates in the urea cycle, a five-enzyme cycle that employs four of the enzymes of arginine biosynthesis to detoxify ammonia through the production of urea. Ammonia detoxification is critical for the survival of higher organisms. In humans, failure to produce functional AS leads to the buildup of citrulline, ammonia, and orotic acid. If untreated, the neurotoxic ammonia can cause brain damage and coma, and in cases where urea cycle function is significantly compromised (less than 5% activity) the condition is typically fatal (1). Finally, AS and a second urea cycle enzyme, argininosuccinate lyase, together with the flavoprotein nitricoxide synthase form the arginine-citrulline cycle, an abbreviated urea cycle that provides de novo arginine biosynthesis for sustainable overproduction of nitric oxide (NO (2, 3)). NO is a small, membrane-permeable, highly reactive molecule that plays key roles in a wide range of mammalian processes including blood pressure control, neurotransmission, apoptosis, immune system function, and wound healing (for reviews, see . AS is the rate-limiting enzyme in both the urea and the arginine-citrulline cycles (11,12) and is therefore a key participant in all thes...